Avalo Therapeutics Inc. – Filings and Transcripts

NASDAQ: AVTX
Share price (8/17/26): $19.95
Market cap (8/17/26): $1.070 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Sullivan Christopher Ryan

Sullivan Christopher Ryan

T. Rowe Price Investment Management, Inc.

Caligan Partners LP

News Filter

Reports Second Quarter 2026 Financial Results and Recent Business Updates

Change in Directors, Officers or Compensation

Expands Pipeline With AVTX-010, a Long-Acting Next-Generation Anti-Il-1β Antibody

Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC